Serena Williams wants to be transparent and is opening up about her fitness journey, revealing she's taking a GLP-1 ...

According to the National Institutes of Health, GLP-1, or Glucagon-like peptide-1, agonists are a class of medications utilised to treat type 2 diabetes mellitus (T2DM) and obesity. As a class of ...

According to the Cleaveland Clinic, GLP-1 agonists (glucagon-like peptide-1 receptor agonists) are injectable medications ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

Daytime TV has gone through many changes — including heartbreaking cancellations and surprising casting swaps — ahead of the ...

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

Serena Williams, the tennis legend with 23 Grand Slam singles titles, has always been admired for her athletic prowess and ...

"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients ...

Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...

Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs ...

Tennis legend Serena Williams, 43, has explained how she has managed to shed a remarkable 31 pounds over the past 18 months ...